Aspartic acid-based modified PLGA–PEG nanoparticles for bone targeting: In vitro and in vivo evaluation

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.6K citations

Medicine, Endocrinology, Bone Metabolism +16

Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery

Jianjun Cheng, Benjamin A. Teply, Ines Sherifi et al. · Biomaterials · 2006 · 1.3K citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14

Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Henry G. Bone, Michael R. McClung, Christian Roux et al. · Journal of Bone and Mineral Research · 2009 · 331 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Nano- and microparticles for the delivery of polypeptides and proteins

Patrick Couvreur, F. Puisieux · Advanced Drug Delivery Reviews · 1993 · 277 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +10

Visualizing Normal and Defective Bone Development in Zebrafish Embryos Using the Fluorescent Chromophore Calcein

Shaojun Du, Victor Frenkel, Greg A. Kindschi et al. · Developmental Biology · 2001 · 261 citations

Medicine, Biology, Developmental Biology +16